Heart Test Laboratories, Inc. Stock
Equities
HSCS
US42254E1047
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0945 USD | +2.05% | -5.41% | -44.74% |
Financials (USD)
Sales 2024 * | 59.3K | Sales 2025 * | 1.9M | Capitalization | 6.2M |
---|---|---|---|---|---|
Net income 2024 * | -6M | Net income 2025 * | -9M | EV / Sales 2024 * | 104 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 3.26 x |
P/E ratio 2024 * |
-0.47
x | P/E ratio 2025 * |
-0.9
x | Employees | 12 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.99% |
1 day | +2.05% | ||
1 week | -5.41% | ||
Current month | +2.27% | ||
1 month | -9.83% | ||
3 months | -28.89% | ||
6 months | -55.23% | ||
Current year | -44.74% |
Managers | Title | Age | Since |
---|---|---|---|
Andrew Simpson
CEO | Chief Executive Officer | 55 | 13-07-24 |
Danielle Watson
DFI | Director of Finance/CFO | 42 | 21-10-31 |
Aaron Peterson
CTO | Chief Tech/Sci/R&D Officer | - | 14-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Hilz
COO | Chief Operating Officer | 66 | 13-07-24 |
David R. Wells
BRD | Director/Board Member | 61 | 22-12-27 |
Andrew Simpson
CEO | Chief Executive Officer | 55 | 13-07-24 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-02 | 0.0945 | +2.05% | 1,330,269 |
24-05-01 | 0.0926 | +0.22% | 637,893 |
24-04-30 | 0.0924 | -4.15% | 998,281 |
24-04-29 | 0.0964 | -1.03% | 1,328,271 |
24-04-26 | 0.0974 | -2.50% | 1,665,925 |
Delayed Quote Nasdaq, May 02, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-44.74% | 6.2M | |
+3.59% | 3.45B | |
-5.85% | 169M | |
-14.17% | 83.57M | |
+31.88% | 60.56M |
- Stock Market
- Equities
- HSCS Stock